CORE update of August 21, 2024: the CORE list of outbreaks and adverse events includes seven activities. A new outbreak of Listeria monocytogenes illnesses (ref #1247) not linked to any identified product has been added to the table. There are a total of 3 cases, and FDA has initiated traceback. For the outbreak of Cyclospora cayetanensis illnesses (ref #1245) linked to an unidentified product, the case count has increased from 21 to 35. FDA has initiated an inspection and sampling. For the outbreak of Salmonella Newport (ref #1248) linked to an unidentified product, the case count has increased from 3 to 4. FDA has initiated an inspection. For the outbreak of Cyclospora cayetanensis (ref #1237), FDA has initiated sampling. The outbreak of Salmonella Irumu (ref #1235) has ended, and the FDA’s investigation has closed. CDC, FDA, and state and local partners conducted epidemiologic and traceback investigations and identified mangoes as the source of illnesses in this outbreak. FDA collected and analyzed product samples as part of the investigation, but all samples were reported as negative for Salmonella. Due to the lack of additional supporting evidence, investigators could not determine a specific contamination source while the outbreak was considered ongoing. This outbreak is over. All products have passed shelf life and are no longer on the market. There is no ongoing risk to public health. The advisory has been updated to include updated sample results for the investigation of illnesses (ref #1233) linked to Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. The outbreak has a total of 145 illnesses, 59 hospitalizations, and potential 2 death in 29 states (AL (4), AZ (11), CA (3), CO (1), FL (6), GA (23), IN (8), IA (5), KS (5), KY (11), MD (2), MN (3), MO (1), MT (3), NV (2), NJ (2), NY (1), NC (17), ND (3), OK (1), OR (1), PA (2), SC (7), SD (1), TN (9), TX (7), VA (3), WA (2), and WI (1)), @
